Deregulation of H19 is associated with cervical carcinoma.


Journal

Genomics
ISSN: 1089-8646
Titre abrégé: Genomics
Pays: United States
ID NLM: 8800135

Informations de publication

Date de publication:
01 2020
Historique:
received: 23 11 2018
revised: 06 05 2019
accepted: 11 06 2019
pubmed: 24 6 2019
medline: 25 8 2020
entrez: 24 6 2019
Statut: ppublish

Résumé

CACX is one of the most common cancer affecting women world-wide. Here, expression microarray analysis revealed 8 over-expressed transcribed pseudogenes (GBP1P1, HLA-DRB6, HLA-H, SLC6A10P, NAPSB, KRT16P2, PTTG3P and RNF126P1), down-regulated 7 lincRNAs (H19, MIR100HG, MEG3, DIO3OS, HOXA11-AS, CD27-AS1 and EPB41L4A-AS) and 6 snoRNAs (SNORD97, SNORD3A, SNORD3C, SNORD3D, SNORA12 and SCARNA9) as DEncGs (log2 fold-change ≥ ±1.0) in CACX. Consequently, down-regulation of lincRNA MEG3 and over-expression of pseudogenes, GBP1P1 and PTTG3P in the microarray analysis were found concordant with the real-time quantitative PCR results upon validation. Then, Ingenuity® Pathway analysis (IPA®) analysis with deregulated DEncGs identified functionally important gene, H19. Further, validation (n = 52) of expression confirmed frequent downregulation of H19 with significant association with its deletion (LOH) and promoter methylation (n = 128) in CACX. Moreover, clinicopathological analysis found Indian CACX patients (n = 26) with alterations of H19 by deletion or, promoter methylation with concomitant low expression have poor prognosis.

Identifiants

pubmed: 31229557
pii: S0888-7543(18)30668-2
doi: 10.1016/j.ygeno.2019.06.012
pii:
doi:

Substances chimiques

H19 long non-coding RNA 0
RNA, Long Noncoding 0
RNA, Small Nucleolar 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

961-970

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Anirban Roychowdhury (A)

Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India.

Sudip Samadder (S)

Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India.

Pijush Das (P)

Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.

Dipanjana Indra Mazumder (DI)

Department of Zoology, Siliguri College, Darjeeling, India.

Ankita Chatterjee (A)

National Institute of Biomedical Genomics, Kalyani, India.

Sankar Addya (S)

Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Ranajit Mondal (R)

Department of Gynecology Oncology, Chittaranjan National Cancer Institute, Kolkata, India.

Anup Roy (A)

Department of Pathology, Nil Ratan Sircar Medical College and Hospital, Kolkata, India.

Susanta Roychoudhury (S)

Saroj Gupta Cancer Centre & Research Institute, Kolkata, India.

Chinmay Kumar Panda (CK)

Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India. Electronic address: ckpanda.cnci@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH